Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
HomeScreenerChatCompanies
Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
Companies/Arvinas, Inc.
Company profile

Arvinas, Inc.

NASDAQ: ARVN · Healthcare · Biotechnology
PublicHQ New Haven, CT · New HavenCIK 0001655759Reports USD
#262 of 1,394 Healthcare companies by revenue40th-percentile growth
EA Score
62C
FH 60DQ 69GM 50SS 65
v0.1 · 65/100 weight · provisional
↑ filing timeliness, workforce scale · ↓ listing tenure, growth stability
Methodology →
Revenue TTM
$89.4M
Rev growth YoY (TTM)
-79.1%
Net income (FY)
-$80.8M
Employees
430
Market cap
$541.3M
OverviewFinancialsSegmentsFilingsESGPeople & Places

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$262.6M$262.6M2025
Net income-$80.8M-$80.8M2025
Operating income-$118.5M-$118.5M2025
Total assets$717.9M$717.9M2025
Liabilities$284.0M$284.0M2025
Equity$433.9M$433.9M2025

Revenue trend

FY2019 – FY2025 · USD
$30.1M
FY19
$18.3M
FY19
$21.8M
FY20
$46.7M
FY21
$131.4M
FY22
$78.5M
FY23
$263.4M
FY24
$262.6M
FY25

Revenue by segment

Filed disclosures · FY2025
By product
License100%
By geography

Not disclosed.

The read

Arvinas, Inc. booked $262.6M in FY2025 revenue, contracting 0.3% year over year — about the middle of the pack among Healthcare companies we track, at a -30.8% net margin.

Peers · Healthcare
AngioDynamics, Inc.72BCandel Therapeutics, Inc.32DXOMA Royalty Corp.75B+PeakBirch Commerce Inc.——
Neighbors
New Haven →
Veradermics, Incorporated——Trevi Therapeutics, Inc.——Biohaven Ltd.——Rallybio Corporation$858.0k47DPrecipio, Inc.$24.2M70BBioXcel Therapeutics, Inc.$642.0k27D
Key facts
CEORandy Teel
SectorHealthcare
IndustryBiotechnology
HeadquartersNew Haven, CT
ExchangeNASDAQ: ARVN
Employees430
IPO date2018-09-27
Latest filings
8-K2026-06-258-K2026-06-228-K2026-06-168-K2026-06-028-K2026-05-128-K2026-05-1210-Q2026-05-118-K2026-05-01
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.
HomeScreenerChatCompanies